Comparative study between hyperbaric levobupivacaine and bupivacaine.

Comparative effect of intrathecal hyperbaric levobupivacaine versus bupivacaine with and without midazolam as adjuvant in lower limb surgery - nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067120

Enrollment

Registered

2024-05-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Spinal anaesthesia: Drug for spinal anaesthesia will be hyperbaric Levo bupivacaine +/- midazolam for duration of 6 months dosage.3 ml bupivacaine with 1mg , midazolam as adjuvant. It i

Eligibility

Inclusion criteria

Inclusion criteria: patient belonging to american society of anesthesiologist grade 1 and grade2

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Hemodynamic parametersTimepoint: 0 to 360 minutes	—

Secondary

Measure	Time frame
Characteristic of sensory and motor blockTimepoint: 0 to 360 minutes;SedationTimepoint: 0 to 360 minutes;To check any adverse effectTimepoint: 0 to 360 minutes	—

Countries

India

Contacts

Public ContactDr Sumita KUmari

institute of medical science

drsumita.1@gmail.com08765514029

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026